Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA
Moat Ross sold 2,367 Kiniksa Pharmaceuticals International, Plc shares (Form 4)
Traded Apr 6 to Apr 7, 2026 · Filed Apr 8, 2026
From Apr 6 to Apr 7, 2026, Moat Ross (CHIEF OPERATING OFFICER) sold 2,367 Kiniksa Pharmaceuticals International, Plc shares at US$48.58 for US$115K under a trading plan, leaving 13,732 shares. Filed Apr 8, 2026 (Form 4).
- Sold
- 2,367 shares
- Price
- US$48.58
- Value
- US$115K
- Holding after
- 13,732 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CHIEF OPERATING OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 6, 2026 | Class A Ordinary Share | Sale | 2,367 | US$48.58 | 12,029 | Direct |
| Apr 7, 2026 | Class A Ordinary Share | Option exercise | 2,477 | 14,506 | Direct | |
| Apr 7, 2026 | Class A Ordinary Share | Shares withheld for tax | 774 | US$48.94 | 13,732 | Direct |
Source
Related
- Kiniksa Pharmaceuticals International, Plc
- Moat Ross
- Kiniksa Pharmaceuticals International, Plc shareholders
- Form 4 · Moat Ross · Sep 3, 2026
- Form 4 · Moat Ross · Apr 13, 2026
- Form 4 · Moat Ross · Apr 3, 2026
- Form 4 · Megna Michael R · Sep 3, 2026
- Form 4 · Paolini John F. · Sep 3, 2026
- Form 4 · Patel Sanj K · Sep 3, 2026
- Form 4 · Ragosa Mark · Sep 3, 2026
- Form 4 · Quart Barry D · Aug 21, 2026